A pivotal study found that NAM was reduced in patients with ALS and that exogenous supplementation of A. muciniphila and NAM in ALS mice increased the serum and cerebrospinal fluid levels of NAM, leading to remission of ALS [66]. This evidence concerns the gene STAC3 and amyotrophic lateral sclerosis.